Report on Re-lodgement of requests for transfer of Physical shares.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has filed a routine compliance report with BSE regarding the re-lodgement of physical share transfer requests, as required under a SEBI circular dated July 2, 2025 which opened a special window for such transfers. The report was prepared by the company's Registrar & Transfer Agent, Venture Capital and Corporate Investments Private Limited. As of November 5, 2025, the number of requests received, processed, approved, and rejected during the month were all reported as NIL. The filing is essentially a nil report indicating no shareholder activity under this special window during the reporting period.
This is a routine compliance disclosure with no material impact on shareholders or the stock price, as it simply confirms that no physical share transfer requests were re-lodged during the reporting period.